Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas

Clinical trial NCT05737212 · TERMINATED

Trial details

NCT number: NCT05737212
Sponsor: Dawonmedax Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent High-grade Glioma Recurrent Glioblastoma Recurrent Anaplastic Astrocytoma Recurrent Anaplastic Oligodendroglioma

Start date: 2022-12-05
Primary completion: 2024-06-11
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.